Are the Symptoms of an NSAID-Induced Ulcer Truly Milder Than Those of an Ordinary Ulcer?

Abstract

Objective The percentage of patients with nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin- (LDA-) induced ulcers who complain of gastrointestinal symptoms has generally been considered to be low. The aim of this study was to examine and compare the symptoms and quality of life (QOL) at peptic ulcer onset. Methods This study involved 200 patients who were confirmed by endoscopy to be in the acute stage of gastroduodenal ulcer (A1-H1). Patients completed a self-administered questionnaire (Global Overall Symptom score and SF-8) at ulcer onset, and data were compared between NSAIDs/LDA ulcers and non-NSAIDs/LDA ulcers. Results The upper gastrointestinal symptoms score was significantly lower for patients using LDA only (20.5 ± 9.4 in the nonusing group, 19.6 ± 8.6 in the NSAIDs-only group, 16.7 ± 11.6 in the LDA-only group, and 18.5 ± 7.2 in the NSAIDs/LDA group, P < 0.05). The QOL score (physical summary) was significantly lower in the NSAID group (42.1 ± 9.9) than in the nonusing group (47.6 ± 7.6) (P < 0.05). Patients' characteristics showed no significant differences among the groups, with the exception of age. Conclusion The severity of upper abdominal symptoms at peptic ulcer onset was similar between NSAID users and nonusers.

Helicobacter pylori and nonmalignant upper gastrointestinal diseases

“…The upper GI symptom score was significantly lower for patients using LDA only ( P < 0.05). The quality of life (QOL) score was significantly lower in the NSAID‐using group (42.1 ± 9.9) than in the nonusing group (47.6 ± 7.6) …”

“…The quality of life (QOL) score was significantly lower in the NSAID-using group (42.1 ± 9.9) than in the nonusing group (47.6 ± 7.6). 9 A Taiwanese group included 12,145 patients taking selective cyclo-oxygenase-2 inhibitors (coxibs) and 12,145 matched controls.…”